References
- Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–568.
- Fazekas F. Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - Commentary. Mult Scler. 2019.
- Filippi M, Rocca MA, Ciccarelli O. et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15:292–303.
- Brownlee WJ, Miszkiel KA, Altmann DR, et al. Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes. Mult Scler. 2017;23:1031–1034.
- Arrambide G, Tintore M, Auger C. et al. Lesion topographies in multiple sclerosis diagnosis: a reappraisal. Neurology. 2017;89:2351–2356.
- Filippi M, Preziosa P, Meani A. et al. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. Lancet Neurol. 2018;17:133–142.
- Thompson AJ, Banwell BL, Barkhof F. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162–173.
- Arrambide G, Tintore M, Espejo C, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain. 2018;141:1075–1084.
- Tintore M, Montalban X. The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - No. Mult Scler. 2018;24:123–125.
- Brownlee WJ, Miszkiel KA, Tur C. et al. Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology. 2018;91:e1130–e4.
- Petzold A. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2018;17:496–497.
- Etemadifar M, Sabeti F. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2018;17:497.
- Schwenkenbecher P, Wurster U, Suhs KW, et al. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2018;17:498.
- Rommer PS, Zettl UK. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2018;17:497–498.
- McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127.
- Hyun JW, Kim W, Huh SY. et al. Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome. Mult Scler. 2018. DOI:10.1177/1352458518790702
- van der Vuurst de VRM, Mescheriakova JY, Wong YYM, et al. Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome. JAMA Neurol. 2018;75:1392–1398.
- Fadda G, Brown RA, Longoni G, et al. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health. 2018;2:191–204.
- Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62:865–870.
- Gobbin F, Zanoni M, Marangi A, et al. 2017 McDonald criteria for multiple sclerosis: earlier diagnosis with reduced specificity? Mult Scler Relat Disord. 2019;29:23–25.
- Sormani MP, Tintore M, Rovaris M, et al. Will Rogers phenomenon in multiple sclerosis. Ann Neurol. 2008;64:428–433.
- Tintore M, Arrambide G, Otero-Romero S, et al. Long term outcomes. Changes in MS prognosis through the CIS Barcelona cohort: a 25-year tale. Mult Scler. 2019;25:33–34.
- Sormani MP, Bruzzi P. MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol. 2013;12:669–676.
- Makhani N, Lebrun C, Siva A. et al. Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome. Mult Scler J Exp Transl Clin. 2019;5. DOI:10.1177/2055217319836664
- Schwenkenbecher P, Konen FF, Wurster U, et al. The persisting significance of oligoclonal bands in the dawning era of kappa free light chains for the diagnosis of multiple sclerosis. Int J Mol Sci. 2018;19(12):E3796.
- Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.